Mesothelioma Cancer Centers
Herbert Irving Comprehensive Cancer Center
Doctors Affiliated with this Treatment Facility
The Herbert Irving Comprehensive Cancer Center is located at New York City’s Columbia University, one of the most respected institutions in the United States. It is one of two cancer centers run by the NewYork-Presbyterian Medical Center, a large medical facility associated with the university. Herbert Irving’s “parent” medical center, NewYork-Presbyterian Medical Center, was formed in 1998 when two historic New York City hospitals – New York Hospital and Presbyterian Hospital – merged into one. That merger formed the largest and most comprehensive medical facility in all of New York State.
Columbia University’s foray into cancer research came more than a century ago when, in 1911, the university launched its first Institute for Cancer Research. The birth of the Herbert Irving Comprehensive Cancer Center came in 1972, when the center received funding from the U.S. government’s National Cancer Institute (NCI); it was designated as a comprehensive cancer center in 1979 and remains one of just 41 NCI-designated comprehensive cancer centers in the United States. Just three of those are located in New York State.
The Herbert Irving Comprehensive Cancer Center(HICCC) features the Columbia University Mesothelioma Center to treat patients with pleural mesothelioma cancer. The Center uses a multidisciplinary approach to treat patients and offers expert care from many departments and specialties. The physicians at the center are constantly performing clinical trials to advance treatment options for patients, with one recent trial analyzes the efficacy of pre- and post-operative chemotherapy and radiation treatment for pleural mesothelioma. Other experimental treatments the center offers includes vaccine therapy and in vitro chemosensitivity testing.
The center has the ability to offer these cutting edge treatments after receiving over $95 million in cancer research grants. The research conducted at the HICCC is split into three divisions: basic, disease-specific and population-based research, enabling further specialization by researchers. All the research conducted at the HICCC is in the hopes of cancer prevention and improving quality of life for patients battling the disease.
- Clinical trials
- In vitro chemosensitivity testing
- Pleural mesothelioma
- Thoracic surgery
- Vaccine therapy
- NCI Center of Excellence in Mesothelioma
- NCI Community Oncology Research Program
- NCI Comprehensive Cancer Center
- U.S. News & World Report Best Hospital Cancer
Mesothelioma Clinical Trials at Herbert Irving Comprehensive Cancer Center
The following clinical trials are in progress or actively recruiting participants at Herbert Irving Comprehensive Cancer Center:
Conditions: Melanoma; Breast Carcinoma; Hepatocellular Carcinoma; Urothelial Carcinoma; Squamous Cell Carcinoma of the Head and Neck; Renal Cell Carcinoma; Colorectal Carcinoma; Non-small Cell Lung Carcinoma; Gastric or Gastroesophageal Junction Adenocarcinoma; Endometrial Carcinoma; Mesothelioma; Neuroendocrine Carcinoma; Cervical Cancer; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of the Anus Last Updated: April 29, 2019 Status: Recruiting
Conditions: Mesothelioma; Bladder Cancer; Melanoma; Squamous Cell Carcinoma of the Head and Neck; Non Small Cell Lung Cancer; Clear Cell Renal Cell Carcinoma; Ovarian Cancer; Thyroid Cancer; Breast Cancer; Pancreatic Cancer; Prostate Cancer; Colon Cancer; Soft Tissue Sarcoma Last Updated: March 5, 2019 Status: Recruiting
Conditions: Solid Tumors; Triple-Negative Breast Cancer; Non Small Cell Lung Cancer; Renal Cell Carcinoma; Mesothelioma; Fumarate Hydratase (FH)-Deficient Tumors; Succinate Dehydrogenase (SDH)-Deficient Gastrointestinal Stromal Tumors (GIST); Succinate Dehydrogenase (SDH)-Deficient Non-gastrointestinal Stromal Tumors; Tumors Harboring Isocitrate Dehydrogenase-1 (IDH1) and IDH2 Mutations; Tumors Harboring Amplifications in the cMyc Gene Last Updated: July 18, 2018 Status: Active, not recruiting
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette
Columbia Surgery. Mesothelioma. General Thoracic Surgery Section.
Columbia University Irving Medical Center. About the Herbert Irving Comprehensive Cancer Center. Herbert Irving Comprehensive Cancer Center.